2015 Pharma Companies Pharmaceuticals Small Molecule 
Drug Discovery World
JANUARY 3, 2023
In the 13 years since it was first described, DNA-encoded library (DEL) technology has become a firmly established approach to small molecule hit generation in drug discovery. Most major pharma companies operate DEL platforms, and several service providers offer DEL capabilities to companies that outsource their DEL activities.
The Pharma Data
OCTOBER 14, 2020
AOP Orphan – AOP Orphan Pharmaceuticals took over the Viennese pharmaceutical company Amomed and the Luxembourgish health-tech company SciPharm. Lanifibranor is believed to be the first drug candidate to be granted this status for the treatment of NASH since January 2015. Growth Programme. Dolmatics – U.K.-based
Expert insights. Personalized for you.
130 
Let's personalize your content